Instituto Roche Forum on Personalized Medicine: Challenges for the next decade

INSTITUTO ROCHE FORUM ON
PERSONALIZED MEDICINE:
CHALLENGES FOR THE NEXT
DECADE

25 de septiembre de 2014, Palacio de Congresos y Exposiciones de Galicia

INSTITUTO ROCHE FORUM ON
PERSONALIZED MEDICINE:
CHALLENGES FOR THE NEXT
DECADE

25 de septiembre de 2014, Palacio de Congresos y Exposiciones de Galicia

Jornada

Opening
Keynote Speech: Moving Genomics to the Clinic: Opportunities and Challenges
Gerardo Jiménez Sánchez.
Harvard School of Public Health, USA and Global Biotech Consulting Group, México.
Session 1:
Scientific and Technologic Advances in Biomedicine

Chairman: Prof. Ángel Carracedo
Director, Galician Public Foundation for Genomic Medicine. Spain.
Genomes, epigenomes and future perspectives in Personalized Medicine
Manel Esteller
Director and Group Leader, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Spain.
Bioinformatics and Big Data in the era of Personalized Medicine
Joaquin Dopazo
Head of the Computational Genomics Department, Centro de Investigación Príncipe Felipe, Spain.
Discussion
-
Coffee Break



Session 2:
Innovation, research and Public Health policies in Personalized Medicine

Chairman: Rafael López
Oncology Director. Complejo Hospitalario Universitario de Santiago. Spain.
European policies in Personalized Medicine
Isabel de la Mata
Principal Advisor with Special Interest in Public Health, DG Health and Consumers, European Commission. Belgium.
Pharma access to external innovation: the example of Roche
María Bobadilla
Senior Director, Extending Innovation Network, Roche Partnering. Switzerland.
Breaking down walls in biomedical research and the challenge of patents in Spain: a success story
Carlos Buesa
Chief Executive Officer. ORYZON. Spain.
Spanish strategy for research on Personalized Medicine: collaborations between academic institutions and the private sector
Antonio L. Andreu
Director, Instituto de Salud Carlos III. Spain.
Discussion
Antonio L. Andreu's questions



-
Lunch



Session 3 Organizada por la AEGH (Asociación Española de Genética Humana)

Biotechnology & human genome sequencing: socio-economic & health impact

Chairman: Javier García Planells
Director Científico de IMEGEN; Presidente de la Asociación Española de Diagnóstico Prenatal. Spain.
Genomic medicine: Opportunities and challenges to the bioeconomy
Gerardo Jiménez-Sánchez
Harvard School of Public Health, USA and Global Biotech Consulting Group, México.
Adoption of Next Generation Sequencing on the National Health System: impact and experience of an early adopter.
Gert Matthijs
Center for Human Genetic, University Hospital, Leuven, Belgium
Implementation of genomic medicine in Spain: lights, shadows and future
Juan C. Cigudosa
Spanish National Cancer Research Center, Madrid. President, Spanish Association of Human Genetics. Spain.
Spanish Human Proteome Project of Chromosome 16: Rheumatologic Application
Cristina Ruiz-Romero
Rheumatology Division. Proteomics Group - ProteoRed-PRB27ISCIII. INIBIC - Hospital Universitario A Coruña. A Coruña - SPAIN
-
Discussion



Localización

Palacio de Congresos e Exposiciones de Galicia
Miguel Ferro Caaveiro s/n - San Lázaro
15707 Santiago de Compostela
Sala Obradoiro

Palacio de Congresos y Exposiciones de Galicia

Organiza